Advisor, Bioanalytical Chemistry
About the role
At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us. Orna Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company, is an innovative biotechnology startup based in Watertown, MA, committed to developing groundbreaking therapies for diseases that current approaches cannot address. With our pioneering circular RNA technology, developed at MIT, we are at the forefront of advancing the next generation of RNA therapeutics. Our pioneering expression and delivery platform positions us to tackle complex diseases, including B cell-driven autoimmune disorders, B cell malignancies, sickle cell disease, and beyond. We are seeking an experienced scientist with expertise in liquid chromatography-mass spectrometry (LC-MS/MS) to lead bioanalytical method development, validation, and sample analysis supporting pharmacokinetic (PK) and protein biomarker assessments across drug development programs. This role will contribute scientific and technical leadership to cross-functional teams supporting discovery studies, including biotherapeutics and novel modalities (e.g., LNP, RNA-based therapeutics).
Responsibilities
- Design, develop, and qualify LC-MS/MS methods for quantifying protein/peptide biomarkers and PK analytes in biological